NeuroMetrix Inc (NURO)

NASDAQ
Currency in USD
4.590
+0.020(+0.44%)
Real-time Data
NURO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
4.4164.600
52 wk Range
2.6604.730
Key Statistics
Edit
Prev. Close
4.585
Open
4.6
Day's Range
4.416-4.6
52 wk Range
2.66-4.73
Volume
8.44K
Average Volume (3m)
13.8K
1-Year Change
18.48%
Book Value / Share
7.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NURO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

NeuroMetrix Company Profile

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Compare NURO to Peers and Sector

Metrics to compare
NURO
Peers
Sector
Relationship
P/E Ratio
−1.2x−2.6x−0.5x
PEG Ratio
−0.050.000.00
Price/Book
0.6x1.0x2.6x
Price / LTM Sales
2.5x1.3x3.0x
Upside (Analyst Target)
-45.9%54.1%
Fair Value Upside
Unlock11.9%9.4%Unlock

Earnings

Latest Release
Feb 22, 2024
EPS / Forecast
-1.43 / --
Revenue / Forecast
1.32B / --
EPS Revisions
Last 90 days

People Also Watch

83.31
HQY
-1.53%
10.420
JG
-1.42%
44.83
AKRO
+0.38%
6.872
KALA
+1.06%
5.685
XERS
+4.70%

FAQ

What Is the NeuroMetrix (NURO) Stock Price Today?

The NeuroMetrix stock price today is 4.59

What Stock Exchange Does NeuroMetrix Trade On?

NeuroMetrix is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for NeuroMetrix?

The stock symbol for NeuroMetrix is "NURO."

What Is the NeuroMetrix Market Cap?

As of today, NeuroMetrix market cap is 9.38M.

What is NeuroMetrix Earnings Per Share?

The NeuroMetrix EPS is -4.39.

From a Technical Analysis Perspective, Is NURO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.